Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT)

NCT04583592 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

295

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Camostat Mesilate
DRUG: Placebo

Sponsor

Sagent Pharmaceuticals Inc.